The European Journal of Health Economics

Raw citation data, Impact Factor, Immediacy Index, Published documents, Citations received, , Most cited papers , Recent citations and documents published in this series in EconPapers.

Create citation feed for this series

Raw data:
IF AIF DOC CIT D2Y C2Y SC(%) CiY II AII 1996 0.17 0 0 0 0.08 1997 0.2 0 0 0 0.08 1998 0.23 0 0 0 0.1 1999 0.31 0 0 0 0.15 2000 0.43 0 0 0 0.19 2001 0.4 0 0 0 0.17 2002 0.43 0 0 0 0.2 2003 0.48 0 0 0 0.22 2004 0.52 0 0 0 0.23 2005 0.59 0 0 0 0.27 2006 0.63 54 17 0 0 1 0.02 0.27
IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y DOC: Number of documents published in year y CIT: Number of citations to the series in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 SC(%): Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y IdI: Immediacy Index: CiY / Documents.   AII: Average Immediacy Index for series in RePEc in year y
Impact Factor:	Immediacy Index:
Documents published:	Citations received:

Most cited documents in this series:

(1) RePEc:spr:eujhec:v:7:y:2006:i:1:p:7-18 The relationship between health care expenditure and health outcomes (2006).
Cited: 7 times.

(2) RePEc:spr:eujhec:v:7:y:2006:i:3:p:204-211 Price regulation and generic competition in the pharmaceutical market (2006).
Cited: 2 times.

(3) RePEc:spr:eujhec:v:7:y:2006:i:1:p:37-45 Fixed budgets as a cost containment measure for pharmaceuticals (2006).
Cited: 2 times.

(4) RePEc:spr:eujhec:v:7:y:2006:i:4:p:223-224 Time for a common standard for cost-effectiveness in Europe? (2006).
Cited: 2 times.

(5) RePEc:spr:eujhec:v:7:y:2006:i:3:p:165-172 A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany (2006).
Cited: 1 times.

(6) RePEc:spr:eujhec:v:8:y:2007:i:3:p:253-266 Patient access to pharmaceuticals: an international comparison (2007).
Cited: 1 times.

(7) RePEc:spr:eujhec:v:7:y:2006:i:1:p:79-83 Off-patent drugs in Italy (2006).
Cited: 1 times.

(8) RePEc:spr:eujhec:v:8:y:2007:i:1:p:1-3 Should we really worry about “launch delays” of new drugs in OECD countries? (2007).
Cited: 1 times.

(9) RePEc:spr:eujhec:v:7:y:2006:i:3:p:212-217 Alcohol-related mortality, drinking behavior, and business cycles (2006).
Cited: 1 times.

(10) RePEc:spr:eujhec:v:7:y:2006:i:3:p:195-203 Determinants of household health expenditure on western institutional health care (2006).
Cited: 1 times.

(11) RePEc:spr:eujhec:v:7:y:2006:i:2:p:99-106 Choices and utilization in dental care (2006).
Cited: 1 times.

(12) RePEc:spr:eujhec:v:8:y:2007:i:3:p:225-236 Variations in activity and practice patterns: a French study for GPs (2007).
Cited: 1 times.

Recent citations received in: | 2006 | 2005 | 2004 | 2003

Recent citations received in: 2006

(1) RePEc:spr:eujhec:v:7:y:2006:i:3:p:218-220 Decision models in the evaluation of psychotropic drugs (2006). The European Journal of Health Economics

Recent citations received in: 2005

Recent citations received in: 2004

Recent citations received in: 2003

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.